G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4

被引:1066
作者
Petit, I
Szyper-Kravitz, M
Nagler, A
Lahav, M
Peled, A
Habler, L
Ponomaryov, T
Taichman, RS
Arenzana-Seisdedos, F
Fujii, N
Sandbank, J
Zipori, D
Lapidot, T [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
[3] Meir Med Ctr, Kefar Sava, Israel
[4] Sheba Med Ctr, Tel Hashomer, Israel
[5] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel
[6] Assaf Harofeh Med Ctr, IL-70300 Zerifin, Israel
[7] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA
[8] Inst Pasteur, Unite Immunol Virale, Paris, France
[9] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan
基金
以色列科学基金会;
关键词
D O I
10.1038/ni813
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Granulocyte colony-stimulating factor (G-CSF)-induced hematopoietic stem cell mobilization is widely used for clinical transplantation; however, the mechanism is poorly understood. We report here that G-CSF induced a reduction of the chemokine stromal cell-derived factor 1 (SDF-1) and an increase in its receptor CXCR4 in the bone marrow (BM), whereas their protein expression in the blood was less affected. The gradual decrease of BM SDF-1, due mostly to its degradation by neutrophil elastase, correlated with stem cell mobilization. Elastase inhibition reduced both activities. Human and murine stem cell mobilization was inhibited by neutralizing CXCR4 or SDF-1 antibodies, demonstrating SDF-1-CXCR4 signaling in cell egress. We suggest that manipulation of SDF-1-CXCR4 interactions may be a means with which to control the navigation of progenitors between the BM and blood to improve the outcome of clinical stem cell transplantation.
引用
收藏
页码:687 / 694
页数:8
相关论文
共 65 条
[11]  
2-6
[12]   Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals [J].
Derdeyn, CA ;
Costello, C ;
Kilby, JM ;
Sfakianos, G ;
Saag, MS ;
Kaslow, R ;
Bucy, RP .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (12) :1063-1071
[13]  
Dutt P, 1998, J IMMUNOL, V161, P3652
[14]   Sulfated glycans induce rapid hematopoietic progenitor cell mobilization: evidence for selectin-dependent and independent mechanisms [J].
Frenette, PS ;
Weiss, L .
BLOOD, 2000, 96 (07) :2460-2468
[15]   Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors [J].
Gazitt, Y .
STEM CELLS, 2000, 18 (06) :390-398
[16]   Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34+ cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients [J].
Gazitt, Y ;
Liu, Q .
STEM CELLS, 2001, 19 (01) :37-45
[17]   Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells [J].
Hattori, K ;
Heissig, B ;
Tashiro, K ;
Honjo, T ;
Tateno, M ;
Shieh, JH ;
Hackett, NR ;
Quitoriano, MS ;
Crystal, RG ;
Rafii, S ;
Moore, MAS .
BLOOD, 2001, 97 (11) :3354-3360
[18]   Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand [J].
Heissig, B ;
Hattori, K ;
Dias, S ;
Friedrich, M ;
Ferris, B ;
Hackett, NR ;
Crystal, RG ;
Besmer, P ;
Lyden, D ;
Moore, MAS ;
Werb, Z ;
Rafii, S .
CELL, 2002, 109 (05) :625-637
[19]   Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers [J].
Hendrix, CW ;
Flexner, C ;
MacFarland, RT ;
Giandomenico, C ;
Fuchs, EJ ;
Redpath, E ;
Bridger, G ;
Henson, GW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1667-1673
[20]   Differential MMP and TIMP production by human marrow and peripheral blood CD34+ cells in response to chemokines [J].
Janowska-Wieczorek, A ;
Marquez, LA ;
Dobrowsky, A ;
Ratajczak, MZ ;
Cabuhat, ML .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (11) :1274-1285